Application 761411
- Type
- BLA
- Sponsor
- INCYTE CORP
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761411 | Niktimvo | axatilimab-csfr | 351(a) | Disc | 2026-10-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NIKTIMVO | axatilimab-csfr | INJECTABLE;INTRAVENOUS | 50 MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NIKTIMVO | AXATILIMAB-CSFR | Incyte Corporation | bb6dba23-e7a6-4765-a1e6-b9e277ce0381 | 2026-09-25 | Warnings, Adverse reactions | BLA761411 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.